Investigation Overview
July 03, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Alliqua Biomedical Inc (NASDAQ:ALQA) was announced over potential breaches of fiduciary duties by certain officers and directors at Alliqua Biomedical.
The investigation by a law firm concerns whether certain Alliqua Biomedical officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Alliqua Biomedical Inc reported that its annual Total Revenue rose from $12.18 million 2015 to $18.24 million in 2016 and that its Net Loss increased from $27.22 million in 2015 to $32.40 million in 2016.
Shares of Alliqua Biomedical Inc (NASDAQ:ALQA) declined from $9.40 per share in early 2014 to as low as $0.32 per share on June 22, 2017